Manju Rajaram

Manju Rajaram

Auto-generated profile, based on publicly available information

Manju Rajaram

Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry 605006, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2014 in Respiratory Care
Verified
Journal Article
Open access
MPManoj Kumar Panigrahi
Manoj Kumar Panigrahi
RMRajaram Manju
Rajaram Manju
SKSaka Vinod Kumar
Saka Vinod Kumar
PTPampa C Toi
Pampa C Toi

10 November 2014 in International Journal of Electronics
Verified
Journal Article
Closed access
GPGENO PETER
GENO PETER
MRM. Rajaram
M. Rajaram
In this paper, an enhanced Z-source inverter (ZSI) is introduced for controlling the speed of permanent magnet brushless DC motor (PMBLDCM) drive. It is the extension of the conventional ZSI and the elements used in the circuit are the same as those of the conventional ZSI, except that the position of Inverter Bridge and diode would be exchanged from the classical circuit diagram. This exchanged circuit avoids the startup path of the inrush current and hence reduces the inrush current and improves the motor efficiency. Different modes of enhanced ZSI are studied with PMBLDCM. The voltage polarity of Z-source capacitors in the proposed circuit is the same as that of the input voltage polarity. Furthermore, to get the same voltage boost, the capacitor voltage stress is reduced to a significant extent. The speed control capability of the proposed brushless DC motor drive is compared with that of the conventional ZSI. The proposed ZSI is implemented in MATLAB/Simulink working platform and the output performance is evaluated. Also, the performance of voltage ratio is analysed both by simulation and mathematical models. All these analyses are known to express the innovative features of the proposed system.

29 August 2021 in Sultan Qaboos University Medical Journal
Verified
Journal Article
Open access
PDF file
RMRavindra Chari M
Ravindra Chari M
MRManju Rajaram
Manju Rajaram
MMMadhusmita M
Madhusmita M
PCPampa ChToi
Pampa ChToi
SLSneha L
Sneha L
Co-infections or consecutive infections of mucormycosis and aspergillosis are very rare. Additionally, distinguishing between these two infections is also difficult as both these conditions have similar clinical features. We report two similar cases from Tamilnadu, who presented to a tertiary care centre in Puducherry, India in 2017 (first case) and 2019 (second case). The first case was a 70-year-old, non-diabetic male patient who presented with haemoptysis with a prior history of pulmonary tuberculosis. Computed tomography bronchial angiography revealed an air-crescent sign and the histopathological examination showed a fungal ball (aspergillus and mucor) in the right upper lobe and foci of fungal infection in the middle lobe. The second case was a 65-year-old diabetic male patient who presented with blackish expectoration and haemoptysis. A high-resolution computed tomography scan showed a reverse-halo sign in the right upper lobe. The results of the bronchoscopy-guided biopsy were consistent with a diagnosis of mixed mucormycosis and aspergillosis with angioinvasion. Both patients responded to amphotericin B with surgical excision of the affected lobe in the first case. A high degree of clinical suspicion, early surgical intervention and antifungal therapy are essential in the treatment of this rare co-infection.

1 January 2023 in Indian Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
MRManju Rajaram
Manju Rajaram
SLSneha Leo
Sneha Leo
MMMadhusmitaMohanty Mohapatra
MadhusmitaMohanty Mohapatra
PCPalanivel Chinnakali
Palanivel Chinnakali
NJNoyalMariya Joseph
NoyalMariya Joseph
MVMaheshBabu Vemuri
MaheshBabu Vemuri
Hods: This study was conducted among HCWs in a teaching hospital in India. We used symptom screening to identify those with presumptive TB and were further evaluated for diagnosis of TB. Results: A total of 1,001 HCWs were screened over a period of 18 months. In our study, 51 (5.1%) HCWs were found to have presumptive TB and on further evaluation, 5 (0.5%) of these patients were diagnosed with active TB. The number needed to screen (NNS) for one active TB among the HCWs was 200. Alcohol use was significantly associated with both presumptive TB (P = 0.037) and active TB (P = 0.035) among HCWs, and exposure to active TB patients (P = 0.014) in the family and workplace and increased frequency of exposures (P = <0.001) were associated with presumptive TB. Conclusion: ACF for TB among HCWs had a good yield in our study. ACF utilizing routine national TB program guidelines is feasible to be implemented among HCWs to aid in the early diagnosis and treatment of TB in this high-risk group....

21 March 2024 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
JPJayabharathi Palanivel
Jayabharathi Palanivel
MMMadhusmita Mohanty Mohapatra
Madhusmita Mohanty Mohapatra
MRManju Rajaram
Manju Rajaram
DGDebasis Gochhait
Debasis Gochhait
SCSunitha Vellathussery Chakkalakkoombil
Sunitha Vellathussery Chakkalakkoombil
RSRakesh Singh
Rakesh Singh
Chronic obstructive pulmonary disease (COPD) patients often experience acute exacerbations requiring hospitalization. Recently, attention has focused on Aspergillus sensitization in the airways of these COPD patients. This study aimed to assess the prevalence of chronic pulmonary aspergillosis (CPA) in COPD patients with acute exacerbations and identify associated risk factors. A cross-sectional descriptive study was conducted at the Jawaharlal Institute of Postgraduate Medical Education and Research from January 2021 to June 2022. Sixty-one COPD patients presenting with acute exacerbations were included. Demographic details, blood investigations, and sputum examinations were performed for all patients. A high-resolution computed tomography thorax was conducted for eligible patients. The prevalence of CPA among patients with an acute exacerbation of COPD was found to be 9.8%, with chronic cavitary pulmonary aspergillosis being the most common presentation (50%). Among post-tubercular COPD patients, the prevalence of CPA was significantly higher at 22.7%. Hemoptysis (p<0.001) and a previous history of tuberculosis (p=0.008) were associated with Aspergillus sensitization. This study highlights the substantial prevalence of CPA in COPD patients with acute exacerbations, particularly in those with a history of tuberculosis. Early recognition and targeted management of CPA in COPD patients may improve outcomes and reduce hospitalization rates. Further large-scale multi-center studies are needed to validate these findings and comprehensively address the impact of CPA on all COPD patients.

5 December 2024 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
SSSadhana Subramanian
Sadhana Subramanian
JGJilisha Gnanadhas
Jilisha Gnanadhas
SSSonali Sarkar
Sonali Sarkar
MRManju Rajaram
Manju Rajaram
SPSenbagavalli Prakashbabu
Senbagavalli Prakashbabu
PCPalanivel Chinnakali
Palanivel Chinnakali
Background: The sustainable development goal (SDG) 3.3.2 prompted India to devise the National Strategic Plan 2017–2025, targeting tuberculosis (TB) eradication by 2030. The prevention pillar of this plan emphasises on Tuberculosis Preventive Treatment (TPT) for those with TB infection (TBI). Healthcare workers (HCWs), identified as one of the high-risk groups by the WHO, show a higher refusal rate for TPT. We aimed to explore the reasons for TPT refusal among the HCWs identified with TBI in Puducherry, South India during 2023. Methods: A qualitative descriptive study was conducted among 12 HCWs from a publicly funded tertiary care hospital, each with at least 5 years of experience. Participants were selected by maximum variation sampling, based on the department of work, current TBI status and subject expertise. The in-depth interviews, guided by the health belief model, lasted approximately 45 min each. Two researchers performed manual thematic analysis using the mixed approach for coding. Codes were grouped into categories and themes. Discrepancies were resolved through discussion with a third researcher, reaching a consensus. Results: Three overarching themes emerged: perceived threats, beliefs regarding health interventions and empowering factors. Perceived threat elucidated the lower perceived vulnerability of contracting TB and minimal chance for progression of TBI to TB disease despite having continuous exposure and uncertainties in the workplace. Beliefs about health interventions included perceived obstacles and advantages, such as testing challenges and lack of awareness, as well as the benefits of prophylaxis and infection control measures. Empowering factors centred on prompting action and self-confidence, highlighting strategies to encourage TBI testing through administrative actions and endorsing shorter treatment plans. Conclusions: Addressing the identified knowledge gaps and false perception through targeted interventions, healthcare institutions can improve TPT uptake. Implementing a comprehensive strategy that combines hospital policies to initiate screening and treatment, a supportive environment and shorter TPT regimens is essential to prevent TB among HCWs.